ENZEAVOUR
LIVE

Serial Number

79411004

Owner

Cosomil, Inc.

Filing Date

Oct 24, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ENZEAVOUR Trademark

Serial Number: 79411004 • Registration: 7821504

ENZEAVOUR is a trademark filed by Cosomil, Inc. on October 24, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Cosomil, Inc. (2 trademarks)

Entrepreneur Lab.,

Entity Type: 99

Trademark Details

Filing Date

October 24, 2024

Registration Date

June 10, 2025

Published for Opposition

April 22, 2025

Goods & Services

In vitro diagnostic preparations for medical use; diagnostic preparations for medical purposes; diagnostic preparations for detecting cancer

Providing cancer screening services; provision of medical information; medical examination services; medical screening; conducting medical physical evaluation services; disease diagnosis services being performing diagnosis of diseases; medical analysis for the diagnosis and treatment of persons; medical counselling; medical testing for diagnostic or treatment purposes; health related consultancy and information services relating to medical products; medical equipment rental; health risk assessment; health care

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 14, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 27, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 27, 2026 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 10, 2025 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 10, 2025 R.PR
PUBLISHED FOR OPPOSITION
Apr 22, 2025 PUBO
NOTICE OF PUBLICATION
Apr 16, 2025 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 25, 2025 CNSA
ASSIGNED TO EXAMINER
Mar 25, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 11, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 11, 2024 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 10, 2024 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 28, 2024 REPR